Explore evidence

46 %From January 1st to 27 October 2024, the testing coverage among suspected mpox cases in the Democratic Republic of the Congo was 46%.

RDCmpoxobserved 2024-01-01 to 2024-10-27Africa CDCdocument of 74 observations

90 health_zonesIn the Democratic Republic of Congo, 90 health zones were classified as moderately endemic for mpox.

RDCmpoxAfrica CDCdocument of 10 observations

4,500 casesIn the Democratic Republic of Congo, there were 4500 mpox cases by week 12 of 2024.

RDCmpoxobserved 2024Africa CDCdocument of 47 observations

43 deathsAs of November 3rd, 2024, there were 43 deaths among confirmed mpox cases in the Democratic Republic of the Congo, with a case fatality ratio of 0.5%.

RDCmpoxobserved November 3rd, 2024Africa CDCdocument of 74 observations

51,000 dosesAs of 1 November 2024, over 51,000 doses of mpox vaccine have been administered in the Democratic Republic of the Congo.

RDCmpoxobserved 2024-11-01Africa CDCdocument of 74 observations

9 laboratoriesThe mpox laboratory decentralization in the Democratic Republic of the Congo increased from 9 laboratories in September 2024 to 19 laboratories by February 2025.

RDCmpoxobserved September 2024Africa CDCdocument of 110 observations

Data from the ongoing DRC outbreak show a pattern of case-fatality ratio for mpox with slightly lower values at young ages and slightly higher values at older ages, attributed to waning vaccine protection as vaccinated cohorts age.

RDCmpoxAfrica CDCdocument of 47 observations

9,376 casesAs of November 3rd, 2024, the Democratic Republic of the Congo reported a cumulative total of 9,376 confirmed mpox cases.

RDCmpoxobserved 2024-11-03Africa CDCdocument of 74 observations

35.8 %Children under 15 years of age constituted 35.8% of confirmed mpox cases in the Democratic Republic of the Congo.

RDCmpoxAfrica CDCdocument of 74 observations

6 countriesAs of 05 September 2024, six countries were experiencing sustained human-to-human mpox transmission: the Democratic Republic of the Congo, Burundi, Nigeria, South Africa, Cote d’Ivoire, and the Central African Republic.

Afrique du Sud · Burundi · Nigeria · RDCmpoxobserved 05 September 2024Africa CDCdocument of 48 observations

11 countriesSustained human-to-human mpox transmission was observed in 11 countries as of February 2025: DRC, Congo Republic, Central African Republic, Burundi, Kenya, Rwanda, Uganda, Zambia, Nigeria, Liberia, and Cote d’Ivoire.

Burundi · Kenya · Liberia · Nigeria · Ouganda · RDC · Rwanda · Zambiempoxobserved February 2025Africa CDCdocument of 110 observations

0.13 N/AThe per-contact transmission probability for mpox is 0.13 in the DRC.

RDCmpoxHAL · Unilimdocument of 70 observations

5.3 %Since September 2023, the newly identified Ib subtype among sex workers in the DRC exhibited high fatality rates of approximately 5.3% overall.

RDCmpoxobserved September 2023HAL · Unilimdocument of 70 observations

60 %60% of the 480 confirmed mpox cases reported in the Democratic Republic of the Congo since 2024 were among males.

RDCmpoxobserved 2024Africa CDCdocument of 47 observations

73.4 %The positivity rate of mpox testing in the Democratic Republic of the Congo was 73.4% over the past six weeks.

RDCmpoxobserved past six weeksAfrica CDCdocument of 74 observations

6 countriesAs of 05 September 2024, six countries are experiencing sustained human-to-human transmission of mpox: DRC, Burundi, Nigeria, South Africa, Cote d’Ivoire, and Central African Republic.

Afrique du Sud · Burundi · Nigeria · RDCmpoxobserved 05 September 2024Africa CDCdocument of 48 observations

50,000 vaccine_doses50,000 LC16m8 vaccine doses were delivered to the Democratic Republic of the Congo for Mpox.

RDCmpoxAfrica CDCdocument of 72 observations

73.4 %The positivity rate among tested suspected mpox cases in the Democratic Republic of the Congo was 73.4%.

RDCmpoxAfrica CDCdocument of 74 observations

1,856 suspected_casesDuring week 39, the Democratic Republic of the Congo reported 1,856 newly suspected mpox cases, including 52 suspected fatalities (case fatality ratio 2.8%).

RDCmpoxAfrica CDCdocument of 147 observations

12,190 casesIn the past 6 weeks (epi week 39 to 44), the Democratic Republic of the Congo documented 12,190 suspected mpox cases.

RDCmpoxobserved epi week 39 to 44Africa CDCdocument of 74 observations

12 %Testing capacity for mpox is 12% in the Democratic Republic of the Congo.

RDCmpoxAfrica CDCdocument of 47 observations

25,000 test_kits25,000 test kits were delivered to the Democratic Republic of the Congo for Mpox diagnostics.

RDCmpoxAfrica CDCdocument of 72 observations

Five countries — DRC, Rwanda, Uganda, Central African Republic and Nigeria — are currently vaccinating against mpox.

Nigeria · Ouganda · RDC · Rwandampoxobserved January-February 2025Africa CDCdocument of 72 observations

25 tons25 tons of non-vaccine Mpox supplies were delivered to the Democratic Republic of the Congo.

RDCmpoxAfrica CDCdocument of 72 observations

Five countries — DRC, Rwanda, Uganda, Central African Republic, and Nigeria — were vaccinating against mpox during January–February 2025.

Nigeria · Ouganda · RDC · Rwandampoxobserved January-February 2025Africa CDCdocument of 72 observations